Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia

Klin Padiatr. 2014 May;226(3):188-9. doi: 10.1055/s-0033-1354387. Epub 2013 Oct 24.

Authors

M Lauten¹, C Güttel², C Härtel¹, B Erdlenbruch³

Affiliations

¹ Department of Pediatrics, UKSH, Campus Lübeck, Germany.
² Department of Pediatrics, HELIOS Kliniken Schwerin, Germany.
³ Department of Pediatrics, Mühlenkreiskliniken, Minden, Germany.

PMID: 24158893
DOI: 10.1055/s-0033-1354387

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Asparaginase / adverse effects
Asparaginase / therapeutic use
Bacterial Infections / chemically induced
Child, Preschool
Cyclophosphamide / adverse effects
Cyclophosphamide / therapeutic use
Cytarabine / adverse effects
Cytarabine / therapeutic use
Daunorubicin / adverse effects
Daunorubicin / therapeutic use
Encephalitis, Herpes Simplex / chemically induced
Encephalitis, Herpes Simplex / diagnosis
Fatal Outcome
Female
Hematopoietic Stem Cell Transplantation
Herpes Simplex / chemically induced*
Herpes Simplex / virology
Humans
Induction Chemotherapy
Infant
Male
Mercaptopurine / adverse effects
Mercaptopurine / therapeutic use
Methotrexate / adverse effects
Methotrexate / therapeutic use
Opportunistic Infections / chemically induced*
Opportunistic Infections / virology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Prednisone / adverse effects
Prednisone / therapeutic use
Simplexvirus / drug effects*
Stomatitis, Herpetic / chemically induced
Stomatitis, Herpetic / virology
Vincristine / adverse effects
Vincristine / therapeutic use
Virus Activation / drug effects*

Substances

Cytarabine
Vincristine
Cyclophosphamide
Mercaptopurine
Asparaginase
Prednisone
Methotrexate
Daunorubicin

Supplementary concepts

AIEOP acute lymphoblastic leukemia protocol